CML-164 Dihydroorotate Dehydrogenase Inhibition Reveals Metabolic Vulnerability in Chronic Myeloid Leukemia

Clinical Lymphoma Myeloma and Leukemia(2022)

引用 0|浏览15
暂无评分
摘要
Our study shows that DHODH inhibition is a promising approach for targeting CML stem/progenitor cells and may help more patients discontinue the therapy. This work was supported by Associazione Italiana per la Ricerca sul Cancro: IG-23344.
更多
查看译文
关键词
CML,chronic myeloid leukemia (CML),dihydroorotate dehydrogenase,Meds433
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要